These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32652182)
41. Ionic Liquid Pretreatment Enhances Skin Penetration of 5-Aminolevulinic Acid: A Promising Scheme for Photodynamic Therapy for Acne Vulgaris. Yu Q; Wu X; Lu Y; Chen Z; Zhu Q; Wu W ACS Appl Bio Mater; 2024 May; 7(5):2899-2910. PubMed ID: 38607995 [TBL] [Abstract][Full Text] [Related]
42. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate. de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933 [TBL] [Abstract][Full Text] [Related]
43. Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells. Chung CW; Kim CH; Lee HM; Kim DH; Kwak TW; Chung KD; Jeong YI; Kang DH Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):503-10. PubMed ID: 23429232 [TBL] [Abstract][Full Text] [Related]
44. A HCl/alcohol formulation increased 5-aminolevulinic acid skin distribution using an ex vivo full thickness porcine skin model. Maisch T; Worlicek C; Babilas P; Landthaler M; Szeimies RM Exp Dermatol; 2008 Oct; 17(10):813-20. PubMed ID: 18380780 [TBL] [Abstract][Full Text] [Related]
45. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid. Calin MA; Gruia Ml; Herascu N; Coman T J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844 [TBL] [Abstract][Full Text] [Related]
46. Fluorescence evaluations for porphyrin formation during topical PDT using ALA and methyl-ALA mixtures in pig skin models. Fujita AK; Rodrigues PG; Requena MB; Escobar A; da Rocha RW; Nardi AB; Kurachi C; de Menezes PF; Bagnato VS Photodiagnosis Photodyn Ther; 2016 Sep; 15():236-44. PubMed ID: 27288253 [TBL] [Abstract][Full Text] [Related]
47. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin. Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130 [TBL] [Abstract][Full Text] [Related]
49. Photodynamic therapy for skin cancer: How to enhance drug penetration? Champeau M; Vignoud S; Mortier L; Mordon S J Photochem Photobiol B; 2019 Aug; 197():111544. PubMed ID: 31295716 [TBL] [Abstract][Full Text] [Related]
50. Enhancement of Photodynamic Therapy for Bowen's Disease Using Plum-Blossom Needling to Augment Drug Delivery. Wu Y; Wang P; Zhang L; Wang B; Wang X Dermatol Surg; 2018 Dec; 44(12):1516-1524. PubMed ID: 29994952 [TBL] [Abstract][Full Text] [Related]
51. Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy. Donnelly RF; McCarron PA; Woolfson AD Photochem Photobiol; 2005; 81(4):750-67. PubMed ID: 15790300 [TBL] [Abstract][Full Text] [Related]
52. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. Donnelly RF; McCarron PA; Lightowler JM; Woolfson AD J Control Release; 2005 Mar; 103(2):381-92. PubMed ID: 15763621 [TBL] [Abstract][Full Text] [Related]
53. [Rapamycin and HPPH Co-Loaded Nanodrug Delivered via Dissolvable Microneedles to Treat Port-Wine Stains]. Hao Y; Xu R; Chen M; Chen Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):433-440. PubMed ID: 38645856 [TBL] [Abstract][Full Text] [Related]
54. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Ross EV; Romero R; Kollias N; Crum C; Anderson RR Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233 [TBL] [Abstract][Full Text] [Related]
55. A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin. Lesar A; Ferguson J; Moseley H Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):191-5. PubMed ID: 19614897 [TBL] [Abstract][Full Text] [Related]
56. Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. Steluti R; De Rosa FS; Collett J; Tedesco AC; Bentley MV Eur J Pharm Biopharm; 2005 Aug; 60(3):439-44. PubMed ID: 15996585 [TBL] [Abstract][Full Text] [Related]
57. Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester. Juzenas P; Sharfaei S; Moan J; Bissonnette R J Photochem Photobiol B; 2002 May; 67(1):11-7. PubMed ID: 12007462 [TBL] [Abstract][Full Text] [Related]
58. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Gerscher S; Connelly JP; Griffiths J; Brown SB; MacRobert AJ; Wong G; Rhodes LE Photochem Photobiol; 2000 Oct; 72(4):569-74. PubMed ID: 11045731 [TBL] [Abstract][Full Text] [Related]
59. Targeting of sebaceous glands by δ-aminolevulinic acid-based photodynamic therapy: An in vivo study. Kosaka S; Miyoshi N; Akilov OE; Hasan T; Kawana S Lasers Surg Med; 2011 Jul; 43(5):376-81. PubMed ID: 21674542 [TBL] [Abstract][Full Text] [Related]
60. Application of 5-aminolevulinic acid and its derivatives for photodynamic therapy in vitro and in vivo. Juzeniene A; Juzenas P; Moan J Methods Mol Biol; 2010; 635():97-106. PubMed ID: 20552342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]